Immunohistochemical Expression of Human Epidermal Growth Factor Receptor 2 (HER2) and p53 in Gastric Adenocarcinoma: A Pilot Study from Northern India

INTRODUCTION: After the recent approval of Trastuzumab (anti-HER2 antibody) for the treatment of HER2 overexpressed Gastric Adenocarcinoma (GA), importance of HER2 testing is increasingly recognized. However, there is paucity of studies for HER2 overexpression in the Indian patients of GA. Similarly...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Diagn Res
Main Authors: Patne, Shashikant C.U., Abhilash, VB, Dixit, Vinod Kumar, Katiyar, Richa, Kumar, Sandip, Singh, Gyan Prakash
Formato: Artigo
Idioma:Inglês
Publicado: JCDR Research and Publications (P) Limited 2017
Assuntos:
Pathology Section
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5483674/
https://ncbi.nlm.nih.gov/pubmed/28658772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2017/25650.9921
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares